China Resources Double Crane (600062.SH) subsidiary Acetazolamide sustained-release capsules have obtained the drug registration certificate.

Zhitong Finance APP news, China Resources Double Crane (600062.SH) announced that its holding subsidiary, Henan Zhongshuai Pharmaceutical Technology Co., Ltd., has recently received the "Drug Registration Certificate" for Acetazolamide Sustained-Release Capsules issued by the National Medical Products Administration. This medicine is the first in China approved for the prevention or improvement of acute mountain sickness. The acquisition of the "Drug Registration Certificate" is regarded as passing the consistency evaluation.